Target Name: KBTBD3
NCBI ID: G143879
Review Report on KBTBD3 Target / Biomarker Content of Review Report on KBTBD3 Target / Biomarker
KBTBD3
Other Name(s): kelch repeat and BTB domain containing 3 | KBTBD3 variant 1 | KBTB3_HUMAN | Kelch repeat and BTB domain containing 3, transcript variant 1 | BTB and kelch domain containing 3 | BTB and kelch domain-containing protein 3 | Kelch repeat and BTB domain-containing protein 3 | kelch repeat and BTB (POZ) domain containing 3 | epididymis secretory sperm binding protein | Kelch repeat and BTB domain-containing protein 3 (isoform 1) | BKLHD3

KBTBD3: A Potential Drug Target for Various Diseases

Kelch repeat and BTB domain containing 3 (KBTBD3) is a protein that is expressed in various tissues of the body, including the brain, heart, and gastrointestinal tract. It is a member of the Kelch repeat protein family, which is a family of proteins that contain a characteristic Kelch repeat sequence in their extracellular domain. The BTB domain, which is located within the protein sequence, is a unique structural feature that is found in a variety of proteins, including proteins involved in cell signaling pathways.

KBTBD3 is a protein that has been identified as a potential drug target in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and the various functions that it is involved in have made it an attractive target for researchers to study and potentially develop new treatments.

One of the functions of KBTBD3 is its role in cell signaling pathways. It is a component of several signaling pathways that are involved in a variety of cellular processes, including cell growth, differentiation, and survival. For example, KBTBD3 is involved in the regulation of cell adhesion, a process that is critical for the development and maintenance of tissues and organs. It is also involved in the regulation of cell signaling pathways that are involved in cancer progression, neurodegenerative diseases, and autoimmune disorders.

In addition to its role in cell signaling pathways, KBTBD3 is also involved in the regulation of cellular processes that are important for the development and maintenance of tissues and organs. For example, it is involved in the regulation of cell division, cell migration, and the formation of tissues and organs. It is also involved in the regulation of cellular processes that are involved in the development and progression of diseases, including cancer.

The unique structure of KBTBD3 has also made it an attractive target for researchers to study and develop new treatments. Its BTB domain, which is located in the protein sequence, is a structural feature that is involved in the regulation of several cellular processes. This makes it an attractive target for researchers to study and develop new treatments that can specifically target this protein.

In conclusion, KBTBD3 is a protein that is expressed in various tissues of the body and is involved in a variety of cellular processes that are important for the development and maintenance of tissues and organs. Its unique structure and the various functions that it is involved in have made it an attractive target for researchers to study and develop new treatments for a variety of diseases. As research continues to advance, it is likely that new treatments will be developed that can specifically target KBTBD3 and improve the health and well-being of individuals with these diseases.

Protein Name: Kelch Repeat And BTB Domain Containing 3

The "KBTBD3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KBTBD3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

KBTBD4 | KBTBD6 | KBTBD7 | KBTBD8 | KC6 | KCMF1 | KCNA1 | KCNA10 | KCNA2 | KCNA3 | KCNA4 | KCNA5 | KCNA6 | KCNA7 | KCNAB1 | KCNAB2 | KCNAB3 | KCNB1 | KCNB2 | KCNC1 | KCNC2 | KCNC3 | KCNC4 | KCND1 | KCND2 | KCND3 | KCNE1 | KCNE2 | KCNE3 | KCNE4 | KCNE5 | KCNF1 | KCNG1 | KCNG2 | KCNG3 | KCNG4 | KCNH1 | KCNH2 | KCNH3 | KCNH4 | KCNH5 | KCNH6 | KCNH7 | KCNH7-AS1 | KCNH8 | KCNIP1 | KCNIP1-OT1 | KCNIP2 | KCNIP3 | KCNIP4 | KCNIP4-IT1 | KCNJ1 | KCNJ10 | KCNJ11 | KCNJ12 | KCNJ13 | KCNJ14 | KCNJ15 | KCNJ16 | KCNJ18 | KCNJ2 | KCNJ2-AS1 | KCNJ3 | KCNJ4 | KCNJ5 | KCNJ5-AS1 | KCNJ6 | KCNJ8 | KCNJ9 | KCNK1 | KCNK10 | KCNK12 | KCNK13 | KCNK15 | KCNK15-AS1 | KCNK16 | KCNK17 | KCNK18 | KCNK2 | KCNK3 | KCNK4 | KCNK5 | KCNK6 | KCNK7 | KCNK9 | KCNMA1 | KCNMB1 | KCNMB2 | KCNMB2-AS1 | KCNMB3 | KCNMB4 | KCNN1 | KCNN2 | KCNN3 | KCNN4 | KCNQ Channels (K(v) 7) | KCNQ1 | KCNQ1DN | KCNQ1OT1 | KCNQ2